O75533 (SF3B1_HUMAN) Homo sapiens (Human)
Splicing factor 3B subunit 1 UniProtKBInterProSTRINGInteractive Modelling
It is possible new templates exist for this target since these models were created.
Available Structures
57 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Cryo-EM structure of human exon-defined spliceosome in the late pre-B state. |
Heteromer O43172; O43290; O43395; O75643; O94906; O95777; P08579; P09661; P14678; P55769; P62304; P62306; P62308; P62310; P62312; P62314; P62316; P62318; P83876; Q12874; Q13435; Q13523; Q15029; Q15393; Q15427; Q15428; Q15459; Q53GS9; Q6P2Q9; Q7RTV0; Q8WVK2; Q8WWY3; Q96DI7; Q9BTD8; Q9BUQ8; Q9BWJ5; Q9UK45; Q9Y333; Q9Y3B4; Q9Y4Y9; Q9Y4Z0; | 100.0 | 1×IHP; 1×MG; 1×GTP; 1×ZN; | |||
| Cryo-EM Structure of the Activated Human Minor Spliceosome (minor Bact Complex) |
Heteromer O15541; O43660; O60231; O75643; P14678; P62304; P62306; P62308; P62314; P62316; P62318; Q13356; Q13435; Q13573; Q15029; Q15393; Q15427; Q5RL73; Q6P2Q9; Q6UX04; Q7RTV0; Q8IYB3; Q8TAD8; Q92917; Q96DI7; Q99459; Q9BRD0; Q9BWG6; Q9BWJ5; Q9BZJ0; Q9H6L4; Q9HCG8; Q9P013; Q9P021; Q9UQ35; Q9Y388; Q9Y3B4; | 100.0 | 1×IHP; 1×GTP; 5×MG; 2×K; 1×G5J; 7×ZN; | |||
| Cryo-EM structure of human exon-defined spliceosome in the early B state. |
Heteromer O43172; O43290; O43395; O43447; O75554; O75643; O94906; O95777; P08579; P09661; P14678; P55769; P62304; P62306; P62308; P62310; P62312; P62314; P62316; P62318; P83876; Q12874; Q13435; Q15029; Q15393; Q15427; Q15428; Q15459; Q2TAY7; Q6P2Q9; Q7RTV0; Q8WWY3; Q96DI7; Q9BWJ5; Q9UK45; Q9Y333; Q9Y3B4; Q9Y4Y9; Q9Y4Z0; | 100.0 | 1×IHP; 1×GTP; 1×MG; 1×ZN; | |||
| Cryo-EM structure of human exon-defined spliceosome in the mature pre-B state. |
Heteromer O43172; O43290; O43395; O75643; O94906; O95777; P08579; P09661; P14678; P55769; P62304; P62306; P62308; P62310; P62312; P62314; P62316; P62318; P83876; Q12874; Q13435; Q13523; Q15029; Q15393; Q15427; Q15428; Q15459; Q53GS9; Q6P2Q9; Q7RTV0; Q8WVK2; Q8WWY3; Q96DI7; Q9BTD8; Q9BUQ8; Q9BWJ5; Q9UK45; Q9Y333; Q9Y3B4; Q9Y4Y9; Q9Y4Z0; | 100.0 | 1×IHP; 1×MG; 1×GTP; 1×ZN; | |||
| Cryo-EM structure of a human activated spliceosome (early Bact) at 4.9 angstrom. |
Heteromer O15541; O43660; O60231; O75643; P08579; P09661; P14678; P62304; P62306; P62308; P62314; P62316; P62318; Q12874; Q13435; Q13573; Q15029; Q15393; Q15427; Q15428; Q15459; Q6P2Q9; Q6UX04; Q7RTV0; Q8TAD8; Q96DI7; Q99459; Q9BRD0; Q9BWJ5; Q9BZJ0; Q9HCG8; Q9P013; Q9Y388; Q9Y3B4; | 100.0 | 1×IHP; 1×GTP; 6×MG; 4×ZN; | |||
| cryo-EM structure of a human activated spliceosome (mature Bact) at 5.1 angstrom. |
Heteromer O15541; O43660; O60231; O60306; O60508; O75643; O75934; P08579; P09661; P14678; P41223; P62304; P62306; P62308; P62314; P62316; P62318; Q12874; Q13435; Q15029; Q15393; Q15427; Q15428; Q15459; Q6P2Q9; Q6UX04; Q7RTV0; Q8TAD8; Q96DI7; Q99459; Q9BRD0; Q9BWJ5; Q9BZJ0; Q9HCG8; Q9HCS7; Q9NW64; Q9P013; Q9UMS4; Q9UNP9; Q9UQ35; Q9Y388; Q9Y3B4; Q9Y3C6; | 100.0 | 1×IHP; 1×GTP; 6×MG; 13×ZN; | |||
| Cryo-EM structure of the human activated spliceosome (late Bact) at 6.5 angstrom |
Heteromer O43660; O60231; O60306; O60508; O75643; O75934; P08579; P09661; P14678; P41223; P62304; P62306; P62308; P62314; P62316; P62318; Q12874; Q13435; Q15029; Q15393; Q15427; Q15428; Q15459; Q6P2Q9; Q7RTV0; Q8TAD8; Q96DI7; Q99459; Q9BRD0; Q9BWJ5; Q9BZJ0; Q9HCG8; Q9HCS7; Q9NW64; Q9P013; Q9UMS4; Q9UNP9; Q9UQ35; Q9Y388; Q9Y3B4; Q9Y3C6; | 100.0 | 1×IHP; 1×ALA; 1×GTP; 6×MG; 10×ZN; | |||
| The cryo-EM structure of human pre-Bact complex |
Heteromer O43660; O60306; O60870; O75643; P08579; P09661; P14678; P41223; P62304; P62306; P62308; P62314; P62316; P62318; Q12874; Q13356; Q13435; Q13573; Q15029; Q15393; Q15427; Q15428; Q15459; Q6P2Q9; Q7RTV0; Q8IYB3; Q8TAD8; Q96DI7; Q99459; Q9BRD0; Q9BWJ5; Q9BZJ0; Q9HCS7; Q9NW64; Q9P013; Q9UNP9; Q9Y388; Q9Y3B4; | 100.0 | 1×GTP; 1×MG; 4×ZN; | |||
| The cryo-EM structure of human Bact-I complex |
Heteromer O15541; O43660; O60231; O60306; O75643; P08579; P09661; P14678; P41223; P62304; P62306; P62308; P62314; P62316; P62318; Q12874; Q13356; Q13435; Q13573; Q15029; Q15393; Q15427; Q15428; Q15459; Q6P2Q9; Q6UX04; Q7RTV0; Q8IYB3; Q8TAD8; Q96DI7; Q99459; Q9BRD0; Q9BWJ5; Q9BZJ0; Q9HCG8; Q9HCS7; Q9NW64; Q9P013; Q9UNP9; Q9UQ35; Q9Y388; Q9Y3B4; | 100.0 | 1×IHP; 1×GTP; 6×MG; 7×ZN; | |||
| Cryo-EM Structure of the human minor pre-B complex (pre-precatalytic spliceosome) U12 snRNP part |
Heteromer P14678; P62304; P62306; P62308; P62314; P62316; P62318; Q13435; Q15393; Q15427; Q7RTV0; Q9BWG6; Q9BWJ5; Q9Y3B4; | 100.0 | 4×ZN; | |||
| The Cryo-EM Structure of the Precusor of Human Pre-catalytic Spliceosome (pre-B complex) |
Heteromer O43172; O43395; O75643; O94906; O95777; P08579; P09661; P14678; P55769; P62304; P62306; P62308; P62310; P62312; P62314; P62316; P62318; P83876; Q12874; Q13435; Q15029; Q15393; Q15427; Q15428; Q15459; Q53GS9; Q6P2Q9; Q7RTV0; Q8WWY3; Q96DI7; Q9BUQ8; Q9BWJ5; Q9UK45; Q9Y333; Q9Y3B4; Q9Y4Y9; Q9Y4Z0; | 100.0 | 1×IHP; 1×GTP; 1×MG; | |||
| Human pre-Bact-2 spliceosome (SF3b/U2 snRNP portion) |
Heteromer O60870; Q12874; Q13435; Q15393; Q15427; Q15428; Q7RTV0; Q8IYB3; Q8TAD8; Q99459; Q9BWJ5; Q9Y388; Q9Y3B4; | 100.0 | ||||
| Human pre-Bact-2 spliceosome |
Heteromer O43660; O60306; O60508; O60870; O75643; P08579; P09661; P14678; P41223; P55081; P62304; P62306; P62308; P62314; P62316; P62318; Q12874; Q13356; Q13435; Q13573; Q15029; Q15393; Q15427; Q15428; Q15459; Q6P2Q9; Q7RTV0; Q8IYB3; Q8NAV1; Q8TAD8; Q8WYA6; Q96DI7; Q96NC0; Q99459; Q9BRD0; Q9BWJ5; Q9BZJ0; Q9BZL1; Q9HCS7; Q9NW64; Q9P013; Q9UNP9; Q9Y388; Q9Y3B4; | 100.0 | 1×GTP; 1×MG; 1×IHP; | |||
| Cryo-EM structure of the cross-exon pre-B+5'ss+ATPgammaS complex |
Heteromer O43172; O43290; O43395; O43447; O75643; O94906; O95777; P08579; P09661; P14678; P55769; P62304; P62306; P62308; P62310; P62312; P62314; P62316; P62318; P83876; Q12874; Q13435; Q15029; Q15393; Q15427; Q15428; Q15459; Q53GS9; Q6P2Q9; Q7RTV0; Q8WWY3; Q96DI7; Q9BUQ8; Q9BWJ5; Q9UK45; Q9Y333; Q9Y3B4; Q9Y4Y9; Q9Y4Z0; | 100.0 | ||||
| Cryo-EM structure of the cross-exon pre-B+5'ss complex |
Heteromer O43172; O43290; O43395; O75643; O94906; O95777; P08579; P09661; P14678; P55769; P62304; P62306; P62308; P62310; P62312; P62314; P62316; P62318; P83876; Q12874; Q13435; Q13523; Q15029; Q15393; Q15427; Q15428; Q15459; Q53GS9; Q6P2Q9; Q7RTV0; Q8WVK2; Q8WWY3; Q96DI7; Q9BTD8; Q9BUQ8; Q9BWJ5; Q9UK45; Q9Y333; Q9Y3B4; Q9Y4Y9; Q9Y4Z0; | 100.0 | ||||
| Cryo-EM structure of the cross-exon pre-B+ATP complex |
Heteromer O43172; O43290; O43395; O43447; O75643; O94906; O95777; P08579; P09661; P14678; P55769; P62304; P62306; P62308; P62310; P62312; P62314; P62316; P62318; P83876; Q12874; Q13435; Q15029; Q15393; Q15427; Q15428; Q15459; Q53GS9; Q6P2Q9; Q7RTV0; Q8WWY3; Q96DI7; Q9BUQ8; Q9BWJ5; Q9UK45; Q9Y333; Q9Y3B4; Q9Y4Y9; Q9Y4Z0; | 100.0 | ||||
| Cryo-EM structure of the cross-exon pre-B+5'ssLNG+ATPyS complex |
Heteromer O43172; O43290; O43395; O43447; O75643; O94906; O95777; P08579; P09661; P14678; P55769; P62304; P62306; P62308; P62310; P62312; P62314; P62316; P62318; P83876; Q12874; Q13435; Q15029; Q15393; Q15427; Q15428; Q15459; Q53GS9; Q6P2Q9; Q7RTV0; Q8WWY3; Q96DI7; Q9BUQ8; Q9BWJ5; Q9UK45; Q9Y333; Q9Y3B4; Q9Y4Y9; Q9Y4Z0; | 100.0 | ||||
| Cryo-EM structure of the cross-exon pre-B complex |
Heteromer O43172; O43290; O43395; O75643; O94906; O95777; P08579; P09661; P14678; P55769; P62304; P62306; P62308; P62310; P62312; P62314; P62316; P62318; P83876; Q12874; Q13435; Q13523; Q15029; Q15393; Q15427; Q15428; Q15459; Q53GS9; Q6P2Q9; Q7RTV0; Q8WVK2; Q8WWY3; Q96DI7; Q9BTD8; Q9BUQ8; Q9BWJ5; Q9UK45; Q9Y333; Q9Y3B4; Q9Y4Y9; Q9Y4Z0; | 100.0 | ||||
| Substrate-bound A-like U2 snRNP |
Heteromer Q12874; Q13435; Q15393; Q15428; Q7RTV0; Q9BWJ5; Q9Y3B4; | 100.0 | 5×ZN; | |||
| human Bact spliceosome core structure |
Heteromer O15541; O43660; O60231; O60306; O60508; O75643; O75934; P08579; P09661; P14678; P41223; P62304; P62306; P62308; P62314; P62316; P62318; Q12874; Q13435; Q13573; Q15029; Q15393; Q15428; Q15459; Q6P2Q9; Q6UX04; Q7RTV0; Q8IYB3; Q8TAD8; Q96DI7; Q99459; Q9BRD0; Q9BWJ5; Q9BZJ0; Q9HCG8; Q9HCS7; Q9NW64; Q9P013; Q9ULR0; Q9UMS4; Q9UNP9; Q9UQ35; Q9Y388; Q9Y3B4; Q9Y3C6; | 100.0 | 11×ZN; 5×MG; 1×IHP; 1×GTP; 2×ADP; | |||
| human Bact spliceosome core structure |
Heteromer O15541; O43660; O60508; P41223; Q13435; Q13573; Q15029; Q15393; Q15428; Q6P2Q9; Q6UX04; Q7RTV0; Q8IYB3; Q99459; Q9BRD0; Q9BWJ5; Q9BZJ0; Q9NW64; Q9P013; Q9UQ35; Q9Y388; Q9Y3B4; Q9Y3C6; | 100.0 | 4×MG; 1×IHP; 1×GTP; 10×ZN; | |||
| human 17S U2 snRNP |
Heteromer O43719; P08579; P09661; P14678; P62304; P62306; P62308; P62314; P62316; P62318; Q12874; Q13435; Q15393; Q15427; Q15428; Q15459; Q7L014; Q7RTV0; Q9BWJ5; Q9Y3B4; | 100.0 | ||||
| Structure of a minimal SF3B core in complex with spliceostatin A (form I) |
Heteromer Q15393; Q7RTV0; Q921M3; Q9BWJ5; | 100 | 3×ZN; 1×SCN; 1×SJT; | |||
| Structure of a minimal SF3B core in complex with pladienolide D (form I) |
Heteromer Q15393; Q7RTV0; Q9BWJ5; | 100 | 1×T2Z; 3×ZN; | |||
| Structure of a minimal SF3B core in complex with sudemycin D6 (form II) |
Heteromer Q15393; Q7RTV0; Q9BWJ5; | 100 | 3×ZN; 1×T2W; | |||
| Structure of a minimal SF3B core in complex with sudemycin D6 (form I) |
Heteromer Q15393; Q7RTV0; Q9BWJ5; | 100 | 3×ZN; 1×T2W; 1×SCN; | |||
| Structure of a minimal SF3B core in complex with spliceostatin A (form II) |
Heteromer Q15393; Q7RTV0; Q9BWJ5; | 100 | 1×SJT; 3×ZN; | |||
| SF3b core in complex with a splicing modulator |
Heteromer Q15393; Q7RTV0; Q9BWJ5; | 100 | 3×ZN; 1×BGZ; | |||
| Crystal structure of the human SF3b core complex |
Heteromer Q15393; Q7RTV0; Q9BWJ5; | 100.0 | 3×ZN; 1×K; | |||
| Structure of a minimal SF3B core in complex with the inactive modulator spliceostatin E (form I) |
Heteromer Q15393; Q7RTV0; Q9BWJ5; | 100 | 1×07I; 3×ZN; | |||
| 5'domain of human 17S U2 snRNP |
Heteromer O43719; Q12874; Q13435; Q15393; Q7L014; Q7RTV0; Q9BWJ5; | 100 | 3×ZN; | |||
| Human pre-Bact-1 spliceosome |
Heteromer O14776; O43660; O75643; O95777; P08579; P09661; P14678; P41223; P52298; P55081; P62304; P62306; P62308; P62310; P62312; P62314; P62316; P62318; Q07955; Q09161; Q12874; Q13435; Q13573; Q15029; Q15393; Q15427; Q15428; Q15459; Q6P2Q9; Q7RTV0; Q8IYB3; Q8NAV1; Q8TAD8; Q96DI7; Q96NC0; Q99459; Q9BWJ5; Q9BZL1; Q9NW64; Q9P013; Q9UK45; Q9Y2W2; Q9Y333; Q9Y3B4; Q9Y4Y9; Q9Y4Z0; | 100.0 | 1×IHP; 1×GTP; 1×MG; 1×GTG; | |||
| Structure of the U2 5' module of the A3'-SSA complex |
Heteromer Q12874; Q13435; Q15393; Q15427; Q15428; Q7RTV0; Q9BWJ5; | 100.0 | 1×SJT; 5×ZN; | |||
| The cryo-EM structure of human Bact-III complex |
Heteromer O15541; O43660; O60231; O60306; O60508; O75643; O75934; P08579; P09661; P14678; P41223; P62304; P62306; P62308; P62314; P62316; P62318; Q12874; Q13356; Q13435; Q13573; Q15029; Q15393; Q15427; Q15428; Q15459; Q6P2Q9; Q7RTV0; Q8WUA2; Q96DI7; Q99459; Q9BWJ5; Q9BZJ0; Q9HCG8; Q9HCS7; Q9NW64; Q9P013; Q9UMS4; Q9UNP9; Q9UQ35; Q9Y3C6; | 100 | 1×IHP; 1×GTP; 7×MG; 7×ZN; | |||
| The cryo-EM structure of human post-Bact complex |
Heteromer O43660; O60231; O60306; O60508; O75934; O95926; P08579; P09661; P14678; P41223; P62304; P62306; P62308; P62314; P62316; P62318; Q13435; Q13573; Q15029; Q15393; Q15427; Q6P2Q9; Q7RTV0; Q8WUA2; Q96DI7; Q99459; Q9BWJ5; Q9BZJ0; Q9HCG8; Q9HCS7; Q9NW64; Q9P013; Q9UMS4; Q9UNP9; Q9UQ35; Q9Y3C6; | 100 | 1×IHP; 1×GTP; 7×MG; 6×ZN; | |||
| The cryo-EM structure of human Bact-II complex |
Heteromer O15541; O43660; O60231; O60306; O75643; P08579; P09661; P14678; P41223; P62304; P62306; P62308; P62314; P62316; P62318; Q12874; Q13356; Q13435; Q13573; Q15029; Q15393; Q15427; Q15428; Q15459; Q6P2Q9; Q7RTV0; Q8WUA2; Q96DI7; Q99459; Q9BWJ5; Q9BZJ0; Q9HCG8; Q9HCS7; Q9NW64; Q9P013; Q9UNP9; Q9UQ35; Q9Y3C6; | 100 | 1×IHP; 1×GTP; 7×MG; 7×ZN; | |||
| The cryo-EM structure of human Bact-IV complex |
Heteromer O15541; O43660; O60231; O60306; O60508; O75934; O95926; P08579; P09661; P14678; P41223; P62304; P62306; P62308; P62314; P62316; P62318; Q12874; Q13435; Q13573; Q15029; Q15393; Q15427; Q6P2Q9; Q7RTV0; Q8WUA2; Q96DI7; Q99459; Q9BWJ5; Q9BZJ0; Q9HCG8; Q9HCS7; Q9NW64; Q9P013; Q9UMS4; Q9UNP9; Q9UQ35; Q9Y3C6; | 100 | 1×IHP; 1×GTP; 7×MG; 7×ZN; | |||
| Structure of a late-stage activated spliceosome (BAqr) arrested with a dominant-negative Aquarius m… |
Heteromer O15541; O43660; O60231; O60306; O60508; O75643; O75934; P08579; P09661; P14678; P41223; P62304; P62306; P62308; P62314; P62316; P62318; Q12874; Q13356; Q13435; Q13573; Q15029; Q15393; Q15427; Q15428; Q15459; Q6P2Q9; Q7RTV0; Q8WUA2; Q92917; Q96DI7; Q99459; Q9BRD0; Q9BWJ5; Q9BZJ0; Q9HCG8; Q9HCS7; Q9NW64; Q9P013; Q9ULR0; Q9UMS4; Q9UNP9; Q9UQ35; Q9Y3C6; | 100 | 12×ZN; 1×IHP; 1×GTP; 7×MG; | |||
| The cryo-EM structure of the human 17S U2 snRNP |
Heteromer O43719; P08579; P09661; P14678; P62304; P62306; P62308; P62314; P62316; P62318; Q12874; Q13435; Q15393; Q15427; Q15428; Q15459; Q7L014; Q7RTV0; Q9BWJ5; | 100 | 1×9B0; 4×ZN; | |||
| The cryo-EM structure of the DDX42-SF3b complex |
Heteromer Q15393; Q7RTV0; Q86XP3; Q9BWJ5; | 100 | 3×ZN; | |||
| Structural organization of a late activated human spliceosome (Baqr, core region) |
Heteromer O15541; O43660; O60231; P14678; P41223; P62304; P62306; P62308; P62314; P62316; P62318; Q12874; Q13356; Q13435; Q13573; Q15029; Q15393; Q15427; Q15428; Q6P2Q9; Q7RTV0; Q8WUA2; Q92917; Q99459; Q9BRD0; Q9BWJ5; Q9BZJ0; Q9HCG8; Q9NW64; Q9P013; Q9UQ35; Q9Y3C6; | 100 | 12×ZN; 1×IHP; 1×GTP; 7×MG; | |||
| The cryo-EM structure of human pre-17S U2 snRNP |
Heteromer O43719; P08579; P09661; P14678; P62304; P62306; P62308; P62314; P62316; P62318; Q12874; Q13435; Q15393; Q15427; Q15428; Q15459; Q7RTV0; Q86XP3; Q9BWJ5; | 100 | 1×9B0; 4×ZN; | |||
| The cryo-EM structure of the human pre-A complex |
Heteromer O75937; P08579; P08621; P09012; P09234; P09661; P14678; P62304; P62306; P62308; P62314; P62316; P62318; Q12874; Q13435; Q15393; Q15427; Q15428; Q15459; Q15637; Q7L014; Q7RTV0; Q9BWJ5; | 100 | 6×ZN; 1×SJT; | |||
| SF3b spliceosomal complex bound to E7107 |
Heteromer Q15393; Q7RTV0; Q9BWJ5; | 100.0 | 1×9B0; 3×ZN; 1×K; | |||
| Cryo-EM structure of a pre-catalytic human spliceosome primed for activation (B complex) |
Heteromer O43172; O43290; O43395; O43447; O75554; O75643; O94906; O95777; P08579; P09661; P14678; P55081; P55769; P62304; P62306; P62308; P62310; P62312; P62314; P62316; P62318; P83876; Q13123; Q15029; Q15393; Q2TAY7; Q6P2Q9; Q7RTV0; Q8NAV1; Q8WWY3; Q96DI7; Q96NC0; Q9BWJ5; Q9UK45; Q9Y333; Q9Y4Y9; Q9Y4Z0; | 100.0 | ||||
| Human 17S U2 snRNP 5' domain |
Heteromer O43719; Q12874; Q13435; Q15393; Q7L014; Q7RTV0; Q9BWJ5; | 100 | 4×ZN; | |||
| U2 snRNP after ATP-dependent remodelling |
Heteromer Q12874; Q13435; Q15393; Q15428; Q7RTV0; Q9BWJ5; | 100 | 5×ZN; | |||
| NMR solution structure of the human spliceosomal protein complex p14-SF3b155 |
Heteromer Q9Y3B4; | 100 | ||||
| Branch Recognition by SF3b14 |
Heteromer Q9Y3B4; | 100 | 1×ADE; | |||
| 2.5 angstrom resolution structure of the spliceosomal protein p14 bound to region of SF3b155 |
Heteromer Q9Y3B4; | 100 | ||||
| 3.0 angstrom resolution structure of a Y22M mutant of the spliceosomal protein p14 bound to a regio… |
Heteromer Q9Y3B4; | 100 | ||||
| human 17S U2 snRNP low resolution part |
Heteromer O43719; P08579; P09661; P14678; P62304; P62306; P62308; P62314; P62316; P62318; Q12874; Q13435; Q15427; Q15428; Q15459; Q7L014; Q9Y3B4; | 100 | ||||
| U2AF65 UHM BOUND TO SF3B155 ULM5 |
Heteromer P26368; | 100 | ||||
| Crystal structure of the UHM domain of human SPF45 in complex with SF3b155-ULM5 |
Heteromer Q96I25; | 100 | ||||
| Crystal structure of human CAPERalpha UHM bound to SF3b155 ULM5 |
Heteromer Q14498; | 100 | 1×K; 1×CL; 1×LYS; | |||
| Structure of HIV Tat-specific factor 1 U2AF Homology Motif bound to U2AF ligand motif 4 |
Heteromer O43719; | 100 | 1×GOL; 1×FMT; | |||
| Structure of HIV Tat-specific factor 1 U2AF Homology Motif bound to SF3b1 ULM5 |
Heteromer O43719; | 100 | 1×PEG; 1×GOL; | |||
6 SWISS-MODEL models
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 7qtt.1.C | monomer | 0.80 | 100.00 | |||
| 7dvq.1.X | monomer | 0.69 | 100.00 | |||
| 5z56.1.1 | monomer | 0.69 | 100.00 | |||
| 7n6g.17.A | monomer | 0.52 | 13.02 | |||
| 6iur.1.B | monomer | 0.52 | 18.38 | |||
| 1b3u.1.A | monomer | 0.52 | 13.61 | |||